E-selectin-inducing activity in plasma from type 2 diabetic patients with maculopathy

American Journal of Physiology - Endocrinology and Metabolism

Volumn 284, Issue 1 47-1, 2003, Pages

  Knudsen, S T ^a   Foss, C H ^a   Poulsen, P L ^a   Bek, T ^a   Ledet, T ^a   Mogensen, C E ^a   Rasmussen, L M ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Adhesion molecules; Diabetic nephropathy; Diabetic retinopathy; Endothelial dysfunction; Macular edema

Indexed keywords

ALBUMIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOSE; HEMOGLOBIN A1C; THYMIDINE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BLOOD PRESSURE; CELL CULTURE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; FEMALE; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; IMPAIRED GLUCOSE TOLERANCE; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN INDUCTION; RETINA MACULOPATHY; VISUAL IMPAIRMENT;

EID: 0037230063     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00198.2002     Document Type: Article

References (34)

1. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, and Klein R. Diabetic retinopathy. Diabetes Care 21: 143-156, 1998.
2. Albertini JP, Valensi P, Lormeau B, Aurousseau MH, Ferriere F, Attali JR, and Gattegno L. Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment. Diabetes Care 21: 1008-1013, 1998.
3. Bagg W, Ferri C, Desideri G, Gamble G, Ockelford P, and Braatvedt GD. The influences of obesity and glycemic control on endothelial activation in patients with type 2 diabetes. J Clin Endocrinol Metab 86: 5491-5497, 2001.
4. Blüher M, Unger R, Rassoul F, Richter V, and Paschke R. Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or type II diabetes. Diabetologia 45:210-216, 2002.
5. Calles-Escandon J and Cipolla M. Diabetes and endothelial dysfunction: A clinical perspective. Endocr Rev 22: 36-52, 2001.
6. Cominacini L, Fratta PA, Garbin U, Campagnola M, Davoli A, Rigoni A, Zenti MG, Pastorino AM, and Lo Cascio V. E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: Possible role of oxidative stress. Diabetologia 40: 584-589, 1997.
7. Fasching P, Veitl M, Rohac M, Streli C, Schneider B, Waldhausl W, and Wagner OF. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81: 4313-4317, 1996.
8. Foss CH, Vestbo E, Froland A, Gjessing HJ, Mogensen CE, and Damsgaard EM. Normal blood pressure and preserved diurnal variation in offspring of type 2 diabetic patients characterized by features of the metabolic syndrome: The Fredericia Study. Diabetes Care 23: 283-289, 2000.
9. Fries JW, Williams AJ, Atkins RC, Newman W, Lipscomb MF, and Collins T. Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. Am J Pathol 143: 725-737, 1993.
10. Hernandez C, Burgos R, Canton A, Garcia-Arumi J, Segura RM, and Simo R. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: A case-control study. Diabetes Care 24: 516-521, 2001.
11. Hirata K, Shikata K, Matsuda M, Akiyama K, Sugimoto H, Kushiro M, and Makino H. Increased expression of selectins in kidneys of patients with diabetic nephropathy. Diabetologia 41: 185-192, 1998.
12. Kado S and Nagata N. Circulating intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 46: 143-148, 1999.
13. Koch AE, Halloran MM, Haskell CJ, Shah MR, and Polverini PJ. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376: 517-519, 1995.
14. Limb GA, Hickman-Casey J, Hollifield RD, and Chignell AH. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 40: 2453-2457, 1999.
15. Matsumoto K, Nakamura H, Ueki Y, Tominaga T, and Miyake S. Correction of hyperglycaemia reduces insulin resistance and serum soluble E-selectin levels in patients with type 2 diabetes mellitus. Diabet Med 18: 224-228, 2001.
16. Matsumoto K, Sera Y, Abe Y, Ueki Y, and Miyake S. Serum concentrations of soluble vascular cell adhesion molecule-1 and E-selectin are elevated in insulin-resistant patients with type 2 diabetes. Diabetes Care 24: 1697-1698, 2001.
17. Morigi M, Angioletti S, Imberti B, Donadelli R, Micheletti G, Figliuzzi M, Remuzzi A, Zoja C, and Remuzzi G. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-KB-dependent fashion. J Clin Invest 101: 1905-1915, 1998.
18. Munro JM. Endothelial-leukocyte adhesive interactions in inflammatory diseases. Eur Heart J 14, Suppl K: 72-77: 72-77, 1993.
19. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000.
20. Nomura S, Shouzu A, Omoto S, Nishikawa M, and Fukuhara S. Significance of chemokines and activated platelets in patients with diabetes. Clin Exp Immunol 121: 437-443, 2000.
21. O'Brien E, Coats A, Owens P, Petrie J, Padfield PL, Littler WA, de Swiet M, and Mee F. Use and interpretation of ambulatory blood pressure monitoring: Recommendations of the British hypertension society. Br Med J 320: 1128-1134, 2000.
22. Okouchi M, Okayama N, Shimizu M, Omi H, Fukutomi T, and Itoh M. High insulin exacerbates neutrophil-endothelial cell adhesion through endothelial surface expression of intercellular adhesion molecule-1 via activation of protein kinase C and mitogen- activated protein kinase. Diabetologia 45: 556-559, 2002.
23. Olson JA, Whitelaw CM, McHardy KC, Pearson DW, and Forrester JV. Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration. Diabetologia 40: 1166-1171, 1997.
24. Rasmussen LM, Hansen PR, Nabipour MT, Olesen P, Kristiansen MT, and Ledet T. Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells. Biochem J 360: 363-370, 2001.
25. a.Rasmussen LM, Schmitz O, and Ledet T. Increased expression of VCAM-1 in cultured endothelial cells exposed to serum from type 1 diabetic patients. No effects of high glucose concentrations. Scand J Clin Lab Invest. In press.
26. Ribau JC, Hadcock SJ, Teoh K, DeReske M, and Richardson M. Endothelial adhesion molecule expression is enhanced in the aorta and internal mammary artery of diabetic patients. J Surg Res 85: 225-233, 1999.
27. Richardson M, Hadcock SJ, DeReske M, and Cybulsky MI. Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. Arterioscler Thromb 14: 760-769, 1994.
28. Ryysy L and Yki-Jarvinen H. Improvement of glycemic control by 1 year of insulin therapy leads to a sustained decrease in sE-selectin concentrations in type 2 diabetes. Diabetes Care 24: 549-554, 2001.
29. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, and Stern D. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96: 1395-1403, 1995.
30. Schroder S, Palinski W, and Schmid-Schonbein GW. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol 139: 81-100, 1991.
31. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, and Matthews DR. UKPDS 50: Risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 44: 156-163, 2001.
32. Suzuma I, Hata Y, Clermont A, Pokras F, Rook SL, Suzuma K, Feener EP, and Aiello LP. Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: Potential mechanisms for exacerbation of diabetic retinopathy by hypertension. Diabetes 50: 444-454, 2001.
33. World Health Organization. Diabetes Mellitus: Report of a WHO Study Group. Geneva: World Health Organization, 1985, 2001. (Tech Rep Ser 727).
34. Yoshizawa M, Nagai Y, Ohsawa K, Ohta M, Yamashita H, Hisada A, Miyamoto I, Miura K, Takamura T, and Kobayashi K. Elevated serum levels of soluble vascular cell adhesion molecule-1 in NIDDM patients with proliferative diabetic retinopathy. Diabetes Res Clin Pract 42: 65-70, 1998.